Adar Poonawalla | |
---|---|
Born | 14 January 1981 |
Citizenship | Indian |
Education | The Bishop's School (Pune) St Edmund's School Canterbury |
Alma mater | University of Westminster |
Occupation | Businessman |
Title | CEO, Serum Institute of India Chairman, Poonawalla Fincorp |
Term | 2011–present |
Spouse | Natasha Poonawalla (m. 2006) |
Children | 2 |
Parent |
|
Website | www |
Adar Poonawalla (born 14 January 1981) is an Indian businessman. He is the chief executive officer of Serum Institute of India and Chairman of Poonawalla Fincorp. [2] [3] His father is Cyrus Poonawalla, founder of the Serum Institute of India. [4]
Adar Poonawalla is the son of Cyrus Poonawala, a Parsi (Zoroastrian). He is married to Natasha Poonawalla and has two children. [1] [5] In December 2023, Poonawalla purchased the most expensive property in London worth Rs 1446 Crore. [6] [7]
Adar Poonawalla was educated at The Bishop's School (Pune) and at the St Edmund's School Canterbury followed by the University of Westminster. [8]
Poonawalla joined the Serum Institute of India in 2001, after graduating from university. Then exporting its products to 35 countries, Poonawalla concentrated on the company's international market, new products license and getting pre-qualified by the World Health Organization for supply to United Nations Agencies including UNICEF and PAHO. As of 2015, he has helped the company export its products to over 140 countries; 85 percent of its revenues are from overseas. [9] [10]
In 2011, he became the CEO. In 2012, he played a major role in the acquisition of Bilthoven Biologicals, a Netherlands-based government vaccine manufacturing company. [11] [12] Poonawalla is a board member of the GAVI Alliance, the global vaccine alliance. [13]
He initiated and launched Serum Institute's oral polio vaccine in 2014, which became a bestseller for the company. It was reported that he planned to expand the product portfolio to include vaccines for dengue, flu, and cervical cancer during the same year. [10] Presently he is the CEO of Serum Institute of India. [14]
On 31 May 2021, he was appointed as the chairman of Poonawalla Fincorp, [15] after acquiring a 66% stake in the financial services company. [16] [17]
In an interview with The Times , Poonawalla declared that he left India for London because of threats demanding COVID-19 vaccines. [18] [19] Poonawalla also said that he will start COVID vaccine production outside India, in addition to the ongoing production in India. [20] [21] He was provided with 'Y' category security by the Indian government as the threats were made public. [22]
In 2020, Serum Institute of India announced that it would donate $66 million to the University of Oxford to fund the creation of the Poonawalla Vaccines Research Building. [23] [24]
Mukesh Dhirubhai Ambani is an Indian businessman and the chairman and managing director of Reliance Industries. With an estimated net worth of $123.3 billion as of July 2024, he is the richest person in Asia and 11th richest in the world. Sometimes characterized as a plutocrat, he has attracted both fame and notoriety for reports of market manipulation, political corruption, cronyism, and exploitation.
Ajay Gopikisan Piramal is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. As of July 2024, his net worth is estimated at US$2.8 billion.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.
Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.
Cyrus S. Poonawalla is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world and Poonawalla Fincorp a leading NBFC in India. In 2022, he is ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. He is ranked number 1 on the Hurun Global Healthcare Rich List 2022.
Poonawalla Fincorp Limited is an Indian non-banking financial company (NBFC) engaged in consumer and MSME financing. It is headquartered in Pune and is part of the Cyrus Poonawalla Group.
Muthoot Pappachan Group, also known as Muthoot Blue, is an Indian financial services conglomerate founded in 1887 by Ninan Mathai Muthoot. Headquartered in Thiruvananthapuram, Kerala, the group has a workforce of more than 26,000 employees across 4,200 branches in India. Apart from financial services, the group has business interests in hospitality, automotive dealerships, real estate, healthcare, IT services, precious metals, alternate energy, and security services.
Nykaa is an Indian e-commerce company headquartered in Mumbai. It sells beauty, wellness and fashion products through its website, mobile app, and over 100 physical stores. In 2020, it became the first Indian unicorn startup headed by a woman.
Lincoln House, owned by billionaire Cyrus Poonawalla, is a 50,000 sq foot heritage property located at 78, Bhulabhai Desai Road, in the billionaires row of Mumbai, India.
The first case of the COVID-19 pandemic was confirmed in the Indian state of Odisha on 16 March 2020. The state has confirmed 10,00,084 cases, including 9,497 active cases, 9,83,245 recoveries, and 7,289 deaths as of 21 August 2021.
The first case of the COVID-19 pandemic in India was reported on 30 January 2020. Slowly, the pandemic spread to various states and union territories including the state of Uttarakhand. The first case was recorded in this region on 15 March.
The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Mizoram. The first case was recorded in this region on 24 March 2020, and the first death was recorded on 28 October 2020.
Events in the year 2021 in India for real time basis.
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.
Vaccine Maitri is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines from 20 January 2021. As of 21 February 2022, India had delivered around 16.29 crore doses of vaccines to 96 countries. Of these, 1.43 crore doses were gifted to 98 countries by the Government of India. The remaining 10.71 crore were supplied by the vaccine producers under its commercial and 4.15 crore were supplied by COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. The Health Minister of India, Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.
Dr. Krishna Ella is an Indian scientist and entrepreneur. He is the founder and Executive Chairman of Bharat Biotech. Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin, World's 1st clinically proven conjugated Typhoid Vaccine, TypbarTCV and ROTAVAC.
Suresh Jadhav was an Indian biotechnology executive and a key member of the Indian vaccine manufacturing industry. At the Serum Institute of India (SII) he led the development and introduction of the Meningococcal A conjugate vaccine to Sub-Saharan Africa and the production of the COVID-19 vaccine at SII, including the ones marketed as Covishield.
BL Agro Industries is an edible oil and food manufacturing company headquartered in Bareilly. Started around the 1950s as an oil trading business, the registered foundation of the organization was laid around the 1970s by Dr. Ghanshyam Khandelwal and joined by his son Ashish Khandelwal in the late 90s. As a commodity trading business, the fast-moving consumer goods firm owns brands like Bail Kolhu, a more than 50-year-old edible oil brand, and Nourish, a food brand that sells products in the staple food category, such as wheat flour, spices, and pulses. The company's turnover stood at Rs 2,173 crore last fiscal year and has over 58,000 direct retailers onboard across 200 Indian cities.